GEN Exclusives

More »

GEN News Highlights

More »
Sep 28, 2006

Ikonisys Obtains Clearance for Prenatal Testing Application

  • Ikonisys’ fastFISH® auto-amniocyte application was cleared for marketing in the U.S. This product allows for the automated identification and enumeration of chromosomes 13, 18, 21, X, and Y in amniotic fluid cells via fluorescence in situ hybridization, or FISH.

    Numerical aberrations of these chromosomes are linked to birth defects, such as down syndrome. The fastFISH auto-amniocyte product is designed to run on the Ikoniscope® robotic digital microscopy platform.

    “We believe that physicians and consumers will appreciate fastFISH® auto-amniocyte’s rapid and reliable functionality,” says Petros Tsipouras, M.D., chairman and CEO.

    “Further, this application provides laboratories with an economical solution to the industry-wide shortage of trained technical personnel,” he adds.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?